BillionToOne, Inc. BLLN
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +9.87%
- 1 year
- -6.02%
5D -13.11 (-12.72%)
- Market cap
- 4.30B
- Revenue (ttm)
- 436.87M
- Profit margin
- 10.52%
- EPS (ttm)
- 0.92
- Shares out
- 43.27M
- P/E ratio
- 97.74
- Forward P/E
- 57.27
- YTD return
- +9.87%
- 1-year return
- -6.02%
- Volume
- 819.50K
- Avg volume
- 635.75K
- Open
- 88.80
- Previous close
- 90.20
- Day's range
- 88.00 – 91.43
- 52-week range
- 64.03 – 149.97
- Analysts
- Strong Buy
- Price target
- 128.29 (+42.7%)
- Earnings date
- Mar 3, 2027
Key statistics
- 50-day average
- 106.58
- 200-day average
- 97.87
- Enterprise value
- 3.89B
- Price / sales
- 9.83
- Price / book
- 7.56
- Revenue growth
- 47.20%
- Free cash flow
- 11.88M
- Total cash
- 561.51M
- Total debt
- 140.45M
- Return on equity
- 13.23%
- Short % of float
- 11.15%
Fundamental scorecard
11 of 25 checks passed on BLLN’s reported financials
11of 25 checks passed
- Value 0 of 5
- Growth 3 of 5
- Profitability 3 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: strong buy
- Target (low)
- 110.00
- Target (mean)
- 128.29
- Target (high)
- 145.00
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
Mar 3, 2027
Expected Mar 3, 2027. Consensus EPS estimate 0.25.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 3, 2027 | Dec 30, 2026 | 0.16 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.146 | 0.32 | +0.17 | +119.18% |
| Aug 5, 2026 | Jun 30, 2026 | 0.1833 | 0.15 | -0.03 | -18.17% |
| May 6, 2026 | Mar 31, 2026 | 0.01 | 0.34 | +0.33 | +3,300.00% |
| Mar 4, 2026 | Dec 31, 2025 | 0.07 | 0.11 | +0.04 | +57.14% |
| Dec 9, 2025 | Sep 30, 2025 | 0.1395 | 0.10 | -0.04 | -28.32% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 10, 2026 | Piper Sandler | main | Overweight | Overweight |
| Nov 5, 2026 | JP Morgan | main | Overweight | Overweight |
| Nov 5, 2026 | BTIG | reit | Buy | Buy |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 2, 2026 | Canaccord Genuity | init | — | Buy |
| Aug 6, 2026 | JP Morgan | main | Overweight | Overweight |
About BillionToOne, Inc.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- billiontoone.com
News
BLLN Investors Have Opportunity to Join BillionToOne, Inc. Fraud Investigation with SBS Law
BLLN INVESTOR ALERT: Investigation of BillionToOne, Inc. Announced by Holzer & Holzer, LLC
Top 3 Health Care Stocks That May Explode In Q4
BillionToOne (BLLN) Faces Investor Scrutiny Related to Short Report Allegations Driving Shares Lower – HBSS
Wolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors
BillionToOne, Inc. Investor News: If You Have Suffered Losses in BillionToOne, Inc. (NASDAQ: BLLN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Lost Money on BillionToOne, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 6.32% Share Price Drop
Did You Lose Money on BillionToOne, Inc. Stock? The Law Offices of Howard G.
Lost Money in BillionToOne, Inc. (NASDAQ: BLLN)? Gibbs Mura is Investigating Potential Securities Law Violations on Behalf of BLLN Investors
Lost Money in BillionToOne, Inc. (NASDAQ: BLLN)? Gibbs Mura is Investigating Potential Securities Law Violations on Behalf of BLLN Investors
Your note
Sign in to keep a note on BLLN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATAY OGUZHAN PH.D. | Chief Executive Officer | Sale | Nov 1, 2026 | 0 |
| BREMNER THOMAS S. | Director | Stock Award(Grant) | Jun 9, 2026 | 11,350 |
| HUMMING BIRD VENTURES MANAGEMENT NV | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 6, 2025 | 0 |
| ILERI FIRAT | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 9, 2026 | 40,331 |
| KOLLURI KRISHNA KITTU | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 9, 2026 | 11,350 |
| LYNCH THOMAS P | General Counsel | Conversion of Exercise of derivative security | Oct 12, 2026 | 10,700 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Adams Street Partners, LLC | 3.96% | 1,711,430 | 153.89M | Sep 29, 2026 |
| Invesco Ltd. | 3.20% | 1,383,470 | 124.40M | Sep 29, 2026 |
| BAILLIE GIFFORD & CO | 2.50% | 1,081,497 | 97.25M | Sep 29, 2026 |
| Price (T.Rowe) Associates Inc | 2.42% | 1,046,609 | 94.11M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 2.35% | 1,018,301 | 91.57M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 1.90% | 822,295 | 73.94M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.67% | 724,088 | 65.11M | Jun 29, 2026 |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 1.23% | 531,370 | 47.78M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.21% | 522,864 | 47.02M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.87% | 377,575 | 33.95M | Jun 29, 2026 |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 0.66% | 286,830 | 25.79M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 0.64% | 275,000 | 24.73M | Jun 29, 2026 |
